View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
September 25, 2017

Qfix introduces new radiotherapy positioning devices

US-based company Qfix has introduced new kVue Access 360 G2 and Access Prone G2 positioning devices for breast cancer radiotherapy.

US-based company Qfix has introduced new kVue Access 360 G2 and Access Prone G2 positioning devices for breast cancer radiotherapy.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

The new devices enable precision treatment by minimising radiation dose to healthy tissue, as well as improving patient comfort and reproducible positioning.

The devices require prone positioning where patients lay face down to allow breast tissue to fall away from the chest wall, which decreases radiation exposure to the heart and lungs by approximately 90%.

Such positioning is also said to enable uniform dose delivery and accurate treatment by minimising respiratory motion.

The devices are designed to connect to the couch top of the radiotherapy machine, allowing the breast tissue to be pulled away from the chest wall by gravity.

"It is reported that prone breast treatment using the firm’s positioning technology demonstrated successful cosmetic outcomes in 80-90% of patients, compared to 60-70% with other methods."

It is reported that prone breast treatment using the firm’s positioning technology demonstrated successful cosmetic outcomes in 80-90% of patients, compared to 60-70% with other methods.

The kVue Access 360 G2 positioning device features an expanded supraclavicular grid to offer complete access for treating nodes in a single set-up.

Compatible with CT and MR, Access Prone G2 comes with low-electron generating technology to reduce skin dose.

The firm has also launched a new respiratory gating platform, SDX 3.0, which has been developed to optimise breathing for management of internal body motion caused by respiration during imaging and radiotherapy.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network